Work

Abstract A020: Applying a functional precision medicine platform, Optim.AI™, to identify novel KRAS inhibitor-based combinations in pancreatic cancer

Year: 2026
Type: conference-abstract
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7133898521
Cites:
Cited by:
Related to: